Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia T Freund

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Allergy and Clinical Immunology|June 4, 2021
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunityDavid Hagin, Tal Freund, Michal Navon, et al.
Iscience|January 23, 2023
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigensRon Yefet, Nadav Friedel, Hadas Tamir, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Nature Communications|March 30, 2018
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelopeChristopher O Barnes, Harry B Gristick, Natalia T Freund, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3Rania Bouzeyen, Nyaradzai Sithole, Avia Watson, et al.
Infection and Immunity|January 21, 2026
Antibodies in tuberculosis: functional capacity as key determinantKrista E van Meijgaarden, Patricia S Grace, Natalia T Freund, et al.
JCI Insight|May 22, 2025
Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancerMichal Navon, Noam Ben-Shalom, Maya Dadiani, et al.
Communications Biology|August 5, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesRuofan Li, Michael Mor, Bingting Ma, et al.
Cell Reports|April 24, 2026
Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survivalNoam Ben-Shalom, Shivang Parikh, Lilach Abramovitz, et al.
Brain, Behavior, and Immunity|June 27, 2023
β2-adrenergic signaling promotes higher-affinity B cells and antibodiesNoam Ben-Shalom, Elad Sandbank, Lilach Abramovitz, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|June 4, 2021
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunityDavid Hagin, Tal Freund, Michal Navon, et al.
Iscience|January 23, 2023
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigensRon Yefet, Nadav Friedel, Hadas Tamir, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Nature Communications|March 30, 2018
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelopeChristopher O Barnes, Harry B Gristick, Natalia T Freund, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3Rania Bouzeyen, Nyaradzai Sithole, Avia Watson, et al.
Infection and Immunity|January 21, 2026
Antibodies in tuberculosis: functional capacity as key determinantKrista E van Meijgaarden, Patricia S Grace, Natalia T Freund, et al.
JCI Insight|May 22, 2025
Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancerMichal Navon, Noam Ben-Shalom, Maya Dadiani, et al.
Communications Biology|August 5, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesRuofan Li, Michael Mor, Bingting Ma, et al.
Cell Reports|April 24, 2026
Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survivalNoam Ben-Shalom, Shivang Parikh, Lilach Abramovitz, et al.
Brain, Behavior, and Immunity|June 27, 2023
β2-adrenergic signaling promotes higher-affinity B cells and antibodiesNoam Ben-Shalom, Elad Sandbank, Lilach Abramovitz, et al.
Pageof 4